ProShare Advisors Portfolio holdings
AUM
$50.1B
This Quarter Return
+3.66%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$9.03B
AUM Growth
+$9.03B
(+26%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
19.33%
Top 10 Holdings %
Top 10 Hldgs %
13.82%
Holding
1,788
New
329
Increased
1,367
Reduced
42
Closed
47
Top Buys
| 1 |
Apple
AAPL
|
$60.1M |
| 2 |
Microsoft
MSFT
|
$46.9M |
| 3 |
Amazon
AMZN
|
$29.6M |
| 4 |
Meta Platforms (Facebook)
META
|
$26.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$26.8M |
Top Sells
| 1 |
LLTC
Linear Technology Corp
LLTC
|
$2.05M |
| 2 |
ProShares Merger ETF
MRGR
|
$1.92M |
| 3 |
Alcoa
AA
|
$1.84M |
| 4 |
RALS
ProShares RAFI Long/Short
RALS
|
$1.34M |
| 5 |
WFM
Whole Foods Market Inc
WFM
|
$1.27M |
Sector Composition
| 1 | Financials | 15.42% |
| 2 | Healthcare | 14.55% |
| 3 | Technology | 12.11% |
| 4 | Consumer Staples | 11.44% |
| 5 | Industrials | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Ocular Therapeutix
OCUL
$2.25B
| – | – |
-17,423
| Closed | -$120K |
|
1777
Larimar Therapeutics
LRMR
$337M
| – | – |
-19,491
| Closed | -$65K |
|
1778
LivaNova
LIVN
$3.09B
| – | – |
-3,430
| Closed | -$206K |
|
1779
Immunic
IMUX
$79.4M
| – | – |
-22,216
| Closed | -$136K |
|
1780
Eledon Pharmaceuticals
ELDN
$155M
| – | – |
-15,256
| Closed | -$23K |
|
1781
Arcturus Therapeutics
ARCT
$467M
| – | – |
-17,384
| Closed | -$43K |
|
|
AFMD
1782
DELISTED
Affimed
AFMD
| – | – |
-20,977
| Closed | -$58K |
|
1783
Adverum Biotechnologies
ADVM
$68.2M
| – | – |
-28,344
| Closed | -$116K |
|
|
CASC
1784
DELISTED
Cascadian Therapeutics, Inc.
CASC
| – | – |
-85,070
| Closed | -$140K |
|
|
RXII
1785
DELISTED
GALENA BIOPHARMA INC COM
RXII
| – | – |
-20,894
| Closed | -$7K |
|
|
CXRX
1786
DELISTED
Concordia International Corp. Common Stock
CXRX
| – | – |
-32,176
| Closed | -$144K |
|